Evidence map›Paper›PMID 40926043›Full record

ReviewNature reviews. Nephrology2025

Improving outcomes in kidney transplantation through advances in donor organ perfusion.

James Hunter, Sarah Hosgood, Cyril Moers, Henri Leuvenink, Ton J Rabelink, Rutger Ploeg, COPE consortium

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Advancements inFrontiers in transplantation · 2026
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James Hunter *Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. james.hunter@nds.ox.ac.uk.
Sarah Hosgood *Department of Surgery, University of Cambridge, Cambridge, UK.
Cyril MoersUniversity of Groningen, University Medical Center Groningen Comprehensive Transplant Center, Groningen, The Netherlands.
Henri LeuveninkUniversity of Groningen, University Medical Center Groningen Comprehensive Transplant Center, Groningen, The Netherlands.
Ton J RabelinkDepartment of Internal Medicine - Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Rutger PloegNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
COPE consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global shortage of suitable donor kidneys is the primary challenge in kidney transplantation, and it is exacerbated by ageing donors with increased numbers of health issues. Improving organ assessment, preservation and conditioning could enhance organ utilization and patient outcomes. Hypothermic machine perfusion (HMP) is associated with better results than static cold storage by reducing delayed graft function and improving short-term graft survival, especially in kidneys recovered from marginal-quality donors. Although HMP is useful for organ preservation, it is difficult to assess organ viability during HMP because of the reduced metabolic activity at low temperatures, and the adoption of HMP has faced logistical challenges. The addition of oxygen during HMP is aimed at reducing ischaemia-reperfusion injury, but has shown mixed results in kidney transplantation, often depending on the duration of perfusion, although some studies found that the addition of oxygen improved outcomes in higher-risk donors. Normothermic machine perfusion helps to restore kidney function by delivering oxygen and nutrients at body temperature, potentially reducing ischaemia-reperfusion injury. Early studies suggest its safety, but clinical benefits remain unproven. Normothermic machine perfusion also holds promise for assessing organ viability pre-transplantation by enabling real-time evaluation. In this Review, we will summarize the different methods of kidney preservation, providing details of the effect that each method has on graft and patient outcomes and the strengths and limitations of each method.

Indexed as

Kidney TransplantationOrgan PreservationPerfusionTissue DonorsGraft SurvivalHumansReperfusion InjuryTreatment Outcome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.